Modulation of contractions to ergonovine and methylergonovine by nitric oxide and thromboxane A2 in the human coronary artery

被引:13
作者
Auch-Schwelk, W
Paetsch, I
Krackhardt, F
Gräfe, M
Hetzer, R
Fleck, E
机构
[1] German Heart Inst, Dept Internal Med Cardiol, Berlin, Germany
[2] German Heart Inst, Dept Cardiac Surg, Berlin, Germany
[3] Humboldt Univ, Klinikum Rudolf Virchow, Berlin, Germany
关键词
endothelium; ergonovine; 5-HT receptors; nitric oxide; thromboxane; vasospasm;
D O I
10.1097/00005344-200011000-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study explored the modulatory effects of nitric oxide and thromboxane A(2) on contractions to ergonovine and methylergonovine in human coronary arteries, To elucidate the different role of nitric oxide synthase in the response to the ergot alkaloids, the serotonin (5-HT) receptors involved in nitric oxide synthase in the response to the ergot alkaloids, the 5-HT receptors involved in nitric oxide release and the contraction of the Vascular smooth muscle were characterized with more selective 5-HT-receptor agonists and antagonists. Rings of human coronary arteries from explanted hearts were suspended in organ chambers for isometric tension recording. After testing for contractile (potassium chloride, 60 mM) and endothelial function (substance P, 10(-8) M), respectively, they were exposed to ergot alkaloids or other agonists in the absence or presence of U 46619 (10(-9) M), or nitro-L-arginine (10(-4) M), or both. Ergonovine and methylergonovine were comparable, weak vasoconstrictors in untreated preparations. Contractions to ergonovine were augmented by U 46619, but not by nitro-L-arginine. Contractions to methylergonovine were augmented only by combining U 46619 and nitro-L-arginine. Serotonin and methylergonovine, but not ergonovine, elicited endothelium-dependent, nitric oxide-mediated relaxations. Nonselective 5-HT1B/1D-receptor stimulation caused both contractions and relaxations; selective 5-HT,, stimulation caused relaxations only. In the human coronary artery, contractions to ergonovine are not dependent on NO release but are synergistically augmented by thromboxane. Methylergonovine causes similar effects on the vascular smooth muscle, but contractions are inhibited by the release of NO from the endothelium. The 5-HT receptor on the endothelium appears to be different from the receptor on the vascular smooth muscle, which mediates the contractile response to the ergot alkaloids.
引用
收藏
页码:631 / 639
页数:9
相关论文
共 42 条
[1]   COOPERATIVE MEDIATION BY SEROTONIN-S2 AND THROMBOXANE-A2 PROSTAGLANDIN-H2 RECEPTOR ACTIVATION OF CYCLIC FLOW VARIATIONS IN DOGS WITH SEVERE CORONARY-ARTERY STENOSES [J].
ASHTON, JH ;
OGLETREE, ML ;
MICHEL, IM ;
GOLINO, P ;
MCNATT, JM ;
TAYLOR, AL ;
RAHEJA, S ;
SCHMITZ, J ;
BUJA, LM ;
CAMPBELL, WB ;
WILLERSON, JT .
CIRCULATION, 1987, 76 (04) :952-959
[2]   5-HT RECEPTORS MEDIATING CONTRACTIONS OF THE ISOLATED HUMAN CORONARY-ARTERY [J].
BAX, WA ;
RENZENBRINK, GJ ;
VANHEUVENNOLSEN, D ;
THIJSSEN, EJM ;
BOS, E ;
SAXENA, PR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) :203-210
[3]   SEROTONIN-5-O-CARBOXYMETHYL-GLYCYL[I-125]TYROSINAMIDE LABELS THE 5-HT(1D-BETA)-RECEPTOR SUBTYPE IN HUMAN CORTEX [J].
BEER, MS ;
MIDDLEMISS, DN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 242 (02) :195-198
[4]   COMPARISON OF RESPONSES TO ACETYLCHOLINE AND SEROTONIN ON ISOLATED CANINE AND HUMAN CORONARY-ARTERIES [J].
BERKENBOOM, G ;
UNGER, P ;
ZHEN, YF ;
DEGRE, S ;
FONTAINE, J .
CARDIOVASCULAR RESEARCH, 1989, 23 (09) :780-787
[5]   FREQUENCY OF PROVOKED CORONARY ARTERIAL SPASM IN 1089 CONSECUTIVE PATIENTS UNDERGOING CORONARY ARTERIOGRAPHY [J].
BERTRAND, ME ;
LABLANCHE, JM ;
TILMANT, PY ;
THIEULEUX, FA ;
DELFORGE, MR ;
CARRE, AG ;
ASSEMAN, P ;
BERZIN, B ;
LIBERSA, C ;
LAURENT, JM .
CIRCULATION, 1982, 65 (07) :1299-1306
[6]   METHERGIN TESTING WITH ANGIOGRAPHICALLY NORMAL CORONARY-ARTERIES [J].
BORY, M ;
JOLY, P ;
BONNET, JL ;
DJIANE, P ;
SERRADIMIGNI, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (04) :298-302
[7]   5-HYDROXYTRYPTAMINE RECEPTOR PROFILE IN HEALTHY AND DISEASED HUMAN EPICARDIAL CORONARY-ARTERIES [J].
CHESTER, AH ;
MARTIN, GR ;
BODELSSON, M ;
ARNEKLONOBIN, B ;
TADJKARIMI, S ;
TORNEBRANDT, K ;
YACOUB, MH .
CARDIOVASCULAR RESEARCH, 1990, 24 (11) :932-937
[8]   INTERACTION BETWEEN THROMBOXANE-A2 AND 5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES IN HUMAN CORONARY-ARTERIES [J].
CHESTER, AH ;
ALLEN, SP ;
TADJKARIMI, S ;
YACOUB, MH .
CIRCULATION, 1993, 87 (03) :874-880
[9]   LOW BASAL AND STIMULATED RELEASE OF NITRIC-OXIDE IN ATHEROSCLEROTIC EPICARDIAL CORONARY-ARTERIES [J].
CHESTER, AH ;
ONEIL, GS ;
MONCADA, S ;
TADJKARIMI, S ;
YACOUB, MH .
LANCET, 1990, 336 (8720) :897-900
[10]   COMPARISON OF CONTRACTILE RESPONSES TO 5-HYDROXYTRYPTAMINE AND SUMATRIPTAN IN HUMAN ISOLATED CORONARY-ARTERY - SYNERGY WITH THE THROMBOXANE A(2)-RECEPTOR AGONIST, U46619 [J].
COCKS, TM ;
KEMP, BK ;
PRUNEAU, D ;
ANGUS, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) :360-368